Syngensys
Synthetic gene promoters and custom genetic components for gene and cell therapy developers and biomanufacturers
Highlights
- New on EvolcAdded 2026-11-07
About Syngensys
Syngensys develops synthetic gene promoters and other genetic components for gene and cell therapies and biomanufacturing. Its work includes tissue-targeted and tuned-expression promoters, promoter design and validation, and signal peptide engineering.
The company serves developers of therapies and biopharmaceutical manufacturing systems through off-the-shelf promoter products and bespoke development projects. Its platform combines bioinformatics analysis, sequence design, testing and validation.
SynGenSys was founded in 2021 and is based in Sheffield, United Kingdom. It describes itself as a growing company working across cell and molecular biology, informatics and engineering.
Product: Synthetic promoters, genetic components and custom design, testing and validation services for biomedical and biomanufacturing applications.
Jobs at Syngensys
Leadership
- Adam Brown · Co-FounderSource: company website
- Andrew Racher · Co-CEOSource: company website
- David James · Co-Founder and Co-CEOSource: company website
More biotech & pharma companies
Synthace
Experiment design, lab automation and AI-ready data software for drug discovery and life science R&D teamsNew on EvolcT-Cypher Bio
Develops immune engager drugs for cancer and autoimmune diseases, built on proprietary wet-lab and computational platformsNew on EvolcTek Optima Research
Custom AI, imaging software and the DeepInsight cell line imaging platform for life sciences and biotech teamsNew on EvolcTheolytics
Develops oncolytic adenovirus immunotherapies for patients with solid tumours and cancers of high unmet needNew on EvolcTheramex
Specialty pharmaceuticals for women’s health, including contraception, fertility, menopause and osteoporosis treatmentsRemote-friendlyTithonia Group
Specialty pharma group that runs a medicine licensing and distribution platform and product brands for prescribers and patients in EuropeNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4Medium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
CRM & customer data
- PipedriveHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.